ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028
TABLE OF CONTENTS
1. ASIA-PACIFIC
VETERINARY VACCINES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE VETERINARY VACCINES MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2. ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VALUE
CHAIN ANALYSIS
2.6. KEY
BUYING CRITERIA
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. CONTRACTS
& AGREEMENTS
2.9.3. PRODUCT
LAUNCHES
2.9.4. EXPANSIONS
& DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. HIGH
VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2. GOVERNMENT-ORGANIZED
VACCINATION DRIVES
2.10.3. ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2. STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12. MARKET
OPPORTUNITIES
2.12.1. EXPANSION
OF THE ANIMAL HEALTHCARE MARKET IN THE ASIA-PACIFIC
2.12.2. RISING
DEMAND FOR COMPANION ANIMALS
3. ASIA-PACIFIC
VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK
ANIMALS
3.1.1. CATTLE
3.1.2. PIGS
3.1.3. POULTRY
3.1.4. SHEEP
3.1.5. OTHER
LIVESTOCK ANIMALS
3.2. COMPANION
ANIMALS
3.2.1. CANINE
3.2.2. FELINE
3.2.3. EQUINE
3.3. AQUACULTURE
4. ASIA-PACIFIC
VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE
DISEASE
4.2. PORCINE
DISEASE
4.3. BOVINE
DISEASE
4.4. POULTRY
DISEASE
4.5. AQUACULTURE
DISEASE
4.6. OTHER
DISEASE TYPE
5. ASIA-PACIFIC
VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED
VACCINES
5.2. INACTIVATED
VACCINES
5.3. TOXOID
VACCINES
5.4. CONJUGATE
VACCINES
5.5. DNA
VACCINES
5.6. RECOMBINANT
VACCINES
5.7. SUBUNIT
VACCINES
6. ASIA-PACIFIC
VETERINARY VACCINES MARKET – COUNTRY OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH
KOREA
6.5. ASEAN
COUNTRIES
6.6. AUSTRALIA
& NEW ZEALAND
6.7. REST
OF ASIA-PACIFIC
7. COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT
BIO PHARMA
7.3. CEVA
SANTE ANIMALE
7.4. ELANCO
ANIMAL HEALTH INC
7.5. HESTER
BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN
IMMUNOLOGICALS LIMITED
7.8. MERCK
ANIMAL HEALTH
7.9. PHIBRO
ANIMAL HEALTH
7.10. VAXXINOVA
GMBH
7.11. VIRBAC
SA
7.12. ZOETIS
INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE LIST
TABLE 1: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: VENDOR SCORECARD
TABLE 4: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY
COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE LIST
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: VALUE CHAIN
ANALYSIS
FIGURE 3: KEY BUYING
CRITERIA
FIGURE 4: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN %)
FIGURE 7: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $
MILLION)
FIGURE 12: ASIA-PACIFIC VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN %)
FIGURE 14: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)
FIGURE 19: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC VETERINARY
VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 26: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 33: ASIA-PACIFIC
VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 34: CHINA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: JAPAN VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: INDIA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: SOUTH KOREA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: ASEAN COUNTRIES
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: AUSTRALIA &
NEW ZEALAND VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: REST OF
ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
MARKET
OUTLOOK
Triton
Market Research has estimated that the veterinary vaccines market in the
Asia-Pacific region will advance at 8.79% CAGR during the forecasting years
2022 to 2028. Japan, India, China, Australia & New Zealand, South Korea, ASEAN
Countries, and Rest of Asia-Pacific outline the market in the given region.
The Asia-Pacific
offers lucrative opportunities for the veterinary vaccines market players. The
focus of international players on investments, R&D, and manufacturing
facilities enhances the importance of veterinary vaccines. Moreover, support
from the government to control and eradicate animal disease has further boosted
the market’s growth.
China
is the 3rd largest country to have 95 million units of cattle. In
this regard, it has emerged as the leading player in the veterinary vaccines
market. Moreover, China is the largest pork producer globally, making it an
important market for the veterinary manufacturing business. Also, the increasing
livestock population in the country has escalated the demand for the vaccine
business. Such factors have benefitted the growth of the veterinary vaccines
market.
Similarly,
India has the largest livestock population worldwide and ranks in the top 5
countries in aquaculture and global fish production. Animal husbandry is
counted as one of the country’s major sources of economic growth, making it necessary
for the country to preserve animal life. As a result, all these factors widen
the growth of the veterinary vaccines market in India.
Get
more Insights into the Asia-Pacific Veterinary Vaccines Market:
https://www.tritonmarketresearch.com/reports/asia-pacific-veterinary-vaccines-market
COMPETITIVE
OUTLOOK
The leading
companies in the veterinary vaccines market include Elanco Animal Health Inc, Boehringer
Ingelheim International GmbH, Indian Immunologicals Limited, Merck Animal
Health, Hipra, and Phibro Animal Health.
SEGMENTATION
1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
2. BRILLIANT
BIO PHARMA
3. CEVA
SANTE ANIMALE
4. ELANCO
ANIMAL HEALTH INC
5. HESTER
BIOSCIENCES LTD
6. HIPRA
7. INDIAN
IMMUNOLOGICALS LIMITED
8. MERCK
ANIMAL HEALTH
9. PHIBRO
ANIMAL HEALTH
10. VAXXINOVA
GMBH
11. VIRBAC
SA
12. ZOETIS
INC
Comments
Post a Comment